Brought to you by 
Coley Pharmaceutical nets $102.6mm in IPO
01 Sep 2005
Executive Summary
Coley Pharmaceutical (developing drugs that stimulate the immune system) has completed its initial public offering, netting $102.6mm through the sale of 6.9mm shares (including the overallotment) for $16 each.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com